| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/28/2009 | CN101352459A 'Fuyi' hypoglycemic agent and preparation method thereof |
| 01/28/2009 | CN101352449A Vitamin orally disintegrating tablet and preparation method thereof |
| 01/28/2009 | CN101352433A Formulation capable of effectively balancing blood pressure, blood fat and promoting cardio-cerebral arterial vascular softening, and preparation method thereof |
| 01/28/2009 | CN101352432A Technique of preparing nano vitamin E emulsion |
| 01/28/2009 | CN101352429A Use of tiopronin in preparing medicament for treating liver function damage induced by cerebral ischemia, diabetes and obesity |
| 01/28/2009 | CN101352426A Osmotic pump controlled release preparation composition and preparation thereof |
| 01/28/2009 | CN101352425A Compound osmotic pump controlled release preparation and preparation method thereof |
| 01/28/2009 | CN101352253A Compound beverage containing collard, red date, haw thorn and chrysanthemum |
| 01/28/2009 | CN101352234A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 01/28/2009 | CN101352213A Five-color total nutrient rice and production method |
| 01/28/2009 | CN101352183A Hypoglycemic bean cake and preparation method thereof |
| 01/28/2009 | CN100455581C Imidazopyridine derivatives as melanocortin receptor agonists. |
| 01/28/2009 | CN100455574C Thiazoline acid derivatives |
| 01/28/2009 | CN100455566C Novel derivatives of aminocyclohexane |
| 01/28/2009 | CN100455299C Application of cultured saussurea medusa and extract thereof in preparation of medicine for treating II type diabetes and its complications |
| 01/28/2009 | CN100455298C Gymnema sylvestre total saponin inclusion compound and its prepn process |
| 01/28/2009 | CN100455295C Dripping pill made from red rice and its preparing method |
| 01/28/2009 | CN100455279C Oral administered sustained release lozenge composition and its preparation method |
| 01/27/2009 | US7482484 Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia |
| 01/27/2009 | US7482458 Quinoline derivatives |
| 01/27/2009 | US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482368 Triamide-substituted heterobicyclic compounds |
| 01/27/2009 | US7482337 Antidiabetic agents; dietetics; antiarthritic agents; osteoporosis; angiotensin converting enzyme inhibitor |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482321 Extended glucagon-like peptide-1 analogs |
| 01/27/2009 | US7482028 Plant derived or derivable material with appetite suppressing activity |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | CA2489407C Lasofoxifene tablet and its coating |
| 01/27/2009 | CA2380757C Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 01/27/2009 | CA2377226C Benzimidazole compounds and medicaments comprising the same |
| 01/27/2009 | CA2377126C Thiazole and oxazole derivatives and their pharmaceutical use |
| 01/27/2009 | CA2355243C Novel 2-(n-cyanoimino)thiazolidin-4-one derivatives |
| 01/27/2009 | CA2322633C An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 01/27/2009 | CA2173846C Cntf family antagonists |
| 01/22/2009 | WO2009012277A1 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| 01/22/2009 | WO2009012275A1 Pyridone gpr119 g protein-coupled receptor agonists |
| 01/22/2009 | WO2009012223A1 Compositions for the treatment of metabolic disorders |
| 01/22/2009 | WO2009012125A1 Compounds and methods for modulating fxr |
| 01/22/2009 | WO2009011617A2 ANNELATED AZAHETEROCYCLES COMPRISING PYRIMIDINE FRAGMENT, METHOD FOR THE PRODUCTION THEREOF AND (PI3Ks) KINASE INHIBITORS |
| 01/22/2009 | WO2009011420A1 Therapeutic agent for type-2 diabetes |
| 01/22/2009 | WO2009011336A1 Quinoline compounds |
| 01/22/2009 | WO2009011285A1 Heteroarylbenzene compounds |
| 01/22/2009 | WO2009011158A1 Rice bran-like composition and food |
| 01/22/2009 | WO2009010560A1 Pyrazole derivatives and use thereof as inhibitors of stearoyl-coa desaturase |
| 01/22/2009 | WO2009010416A2 Inhibitors of 11b-hydroxysteroid dehydrogenase |
| 01/22/2009 | WO2009010299A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 01/22/2009 | WO2009009952A1 An extract of rehmannia glutinasa libosch. for reducing blood sugar, reducing blood fat, treating leukemia and preparation method and uses thereof |
| 01/22/2009 | WO2008144346A3 Crystal structures of sglt2 inhibitors and processes for their preparation |
| 01/22/2009 | WO2008076447A3 Treatments of therapy-resistant diseases comprising drug combinations |
| 01/22/2009 | WO2008063766A3 Amorphous ezetimibe and the production thereof |
| 01/22/2009 | US20090023913 Glucopyranosyl-substituted phenyl derivates, medicaments containing such compounds, their use and process for their manufacture |
| 01/22/2009 | US20090023802 liquid-crystal media used in electro-optical displays; treatment or prophylaxis of diseases or symptoms which can be influenced by inhibition of cannabinoid receptors |
| 01/22/2009 | US20090023800 Cannabinoid receptor modulator |
| 01/22/2009 | US20090023785 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/22/2009 | US20090023770 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 01/22/2009 | US20090023763 Condensed Pyridine Derivatives Useful as A2B Adenosine Receptor Antagonists |
| 01/22/2009 | US20090023749 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023732 Citrate Salt of an Indole Derivative and its Pharmaceutical Use |
| 01/22/2009 | US20090023724 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 01/22/2009 | US20090023709 Inhibitors of 11B-Hyrdoxysteroid Dehydrogenase |
| 01/22/2009 | US20090023703 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase |
| 01/22/2009 | US20090023683 Complexes comprising zoledronic acid and cyclodextrins |
| 01/22/2009 | US20090023682 Composition Comprising Dietary Fat Complexer and Methods of Using Same |
| 01/22/2009 | US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA) |
| 01/22/2009 | US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| 01/22/2009 | US20090023672 Age-2 aptamer |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023639 Methods of Treatment |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090022792 Vitamin D content uniformity in pharmaceutical dosage forms |
| 01/22/2009 | US20090022784 Systems, devices, and methods for iontophoretic delivery of compositions including liposome-encapsulated insulin |
| 01/22/2009 | US20090022758 Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilization of glycemia |
| 01/22/2009 | US20090022743 Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells |
| 01/22/2009 | US20090022733 Methods for treating Disease with an IL-1R antibody |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022705 Chloroplasts engineered to express pharmaceutical proteins in edible plants |
| 01/22/2009 | US20090022702 Methods for introducing mannose 6-phosphate and other oligosacharides onto glycoproteins |
| 01/22/2009 | US20090022694 Sirt1 inhibition |
| 01/22/2009 | US20090022669 Compositions for protein delivery via the pulmonary route |
| 01/22/2009 | DE102007032832A1 Fermenting sunchoke, useful e.g. to reduce blood pressure, comprises crushing the sunchoke, mixing mash with microorganisms, providing a cask, pressing mash to juice, filling the juice into a cask, storing, removing and cleaning the juice |
| 01/22/2009 | CA2789123A1 Insulinotropic peptide derivative wherein its n-terminal amino acid is modified |
| 01/22/2009 | CA2789112A1 Insulinotropic peptide derivative wherein its n-terminal amino acid is modified |
| 01/22/2009 | CA2696833A1 Disease treatment via antimicrobial peptides or their inhibitors |
| 01/22/2009 | CA2693842A1 Rice bran-like composition and food |
| 01/22/2009 | CA2693444A1 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| 01/22/2009 | CA2693439A1 Pyridone gpr119 g protein-coupled receptor agonists |
| 01/22/2009 | CA2693406A1 Compounds and methods for modulating fxr |
| 01/22/2009 | CA2692768A1 Compositions for the treatment of metabolic disorders |
| 01/21/2009 | EP2017338A1 Muscle-specific expression vectors |
| 01/21/2009 | EP2017337A1 Human tumor necrosis factor receptors |
| 01/21/2009 | EP2017251A1 Method for stabilization of reduced coenzyme q10 |
| 01/21/2009 | EP2016953A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 01/21/2009 | EP2016946A1 Chitosan silicon dioxide coprecipitate composition for use as a therapeutically active agent |
| 01/21/2009 | EP2016944A2 Angiogenesis inhibitor containing a derivative of rifampicin |
| 01/21/2009 | EP2016943A1 Substituted tetrahydro-quinoline-sulfonamide compounds, their preparation and use as medicaments |